Role of sub-activation-threshold TCR interactions in maintaining T cell memory
亚激活阈值 TCR 相互作用在维持 T 细胞记忆中的作用
基本信息
- 批准号:8818536
- 负责人:
- 金额:$ 38.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-12-01 至 2019-11-30
- 项目状态:已结题
- 来源:
- 关键词:Adoptive ImmunotherapyAdoptive TransferAffectAgonistAntigen-Presenting CellsAntigensAutoimmune DiseasesAutoimmunityCD4 Positive T LymphocytesCell CountCell DensityCell SurvivalCellsCommunicable DiseasesComputer SimulationCytokine ReceptorsDataDiseaseDoseDrug TargetingEnsureFrequenciesIL7 geneImmune responseImmune systemImmunityImmunizationImmunologic MemoryIndividualInfectionInfluenzaInterleukin-15LigandsLongevityMaintenanceMalariaMediatingMemoryMethodologyModelingMolecularMusNaturePathway interactionsPeptide/MHC ComplexPeptidesPeripheralPhenotypePlasmodiumPlasmodium bergheiPopulationProtocols documentationReagentRewardsRoleSignal TransductionSpecificityT cell responseT memory cellT-Cell ActivationT-Cell Immunologic SpecificityT-LymphocyteT-Lymphocyte SubsetsTCR ActivationTestingTimeToxoplasmaTransgenic OrganismsTransplantationVaccinationVaccine DesignVaccinesWorkbasecohortcytokinedeep sequencingdensitydesignexperienceimprovedin vivoinnovationmembermemory CD4 T lymphocytenovelpathogenpreferencepressurepreventpublic health relevancereceptor expressionresponsescreeningtumor
项目摘要
DESCRIPTION (provided by applicant): In this project we examine how immunological memory formed during one infection is protected from erasure in the face of repeated subsequent infections by multiple unrelated pathogens. This is significant because stable memory is essential for immunizations to successfully confer lifelong protective immunity. Understanding this mechanism will allow us to improve vaccines that otherwise require frequent boosting and even develop new ones for diseases such as malaria. Although cytokines such as IL7 and IL-15 maintain the absolute size of the memory T cell pool in the immune system, the pathways ensuring that the population includes adequate representation of all the previous experiences, is not known. Based on our recent work, we hypothesize that the maintenance of a diverse CD4+ memory repertoire requires trophic interactions of memory T cells with endogenous sub- threshold ligands (STLs). STLs are distinct peptide-MHC complexes that are too weak to stimulate conventional T cell activation. Since only a small proportion of memory cells engage a particular STL, competition for survival is limited to these small "colonies" of T cells. The significance of this mechanism is that it avoids a much broader repertoire loss that might happen if the competition was more widespread. We have generated unique reagents and developed methodologies to test this innovative hypothesis using two major independent and complimentary aims. 1. Establish how TCR-specificity determines which T cells can compete during memory maintenance, using recently identified TCRs that either share antigen-specificity or STL-specificity. We will examine the cellular mechanisms for such competition and establish the range of impact it has on a polyclonal repertoire of T cells. 2. Using sequential infections with Plasmodium, Influenza and Toxoplasma, evaluate how pre-existing memory T cells can be destabilized by the response to a new infection. We will also explore how STL- treatment can help restore the stability of memory T cells in this context. On completion, we expect to offer a novel understanding of CD4+ memory maintenance and suggest strategies to improve memory T cell survival during adoptive therapies and vaccinations. The converse strategies can help decrease the frequency of pathogenic T cells during autoimmunity and transplantation.
描述(由申请人提供):在这个项目中,我们研究了在一次感染期间形成的免疫记忆是如何在面对多个不相关病原体的重复感染时免于消除的。这一点很重要,因为稳定的记忆对于成功地赋予终身保护性免疫至关重要。了解这一机制将使我们能够改进疫苗,否则需要频繁增强,甚至开发针对疟疾等疾病的新疫苗。尽管诸如il - 7和IL-15之类的细胞因子维持了免疫系统中记忆T细胞库的绝对大小,但确保群体包括所有先前经历的充分代表的途径尚不清楚。基于我们最近的工作,我们假设维持不同的CD4+记忆库需要记忆T细胞与内源性亚阈配体(STLs)的营养相互作用。stl是一种独特的肽- mhc复合物,它太弱而不能刺激传统的T细胞活化。由于只有一小部分记忆细胞参与特定的STL,因此生存竞争仅限于这些小的T细胞“菌落”。这种机制的意义在于,它避免了如果竞争更广泛可能发生的更大范围的曲目损失。我们已经产生了独特的试剂和开发的方法来测试这一创新的假设使用两个主要的独立和互补的目标。1. 利用最近发现的共享抗原特异性或stl特异性的tcr,确定tcr特异性如何决定哪些T细胞可以在记忆维持过程中竞争。我们将研究这种竞争的细胞机制,并确定它对T细胞多克隆库的影响范围。2. 利用疟原虫、流感和弓形虫的连续感染,评估对新感染的反应如何破坏预先存在的记忆T细胞的稳定性。我们还将探讨在这种情况下,STL治疗如何帮助恢复记忆T细胞的稳定性。在完成后,我们期望对CD4+记忆维持提供新的理解,并提出在过继治疗和疫苗接种期间提高记忆T细胞存活率的策略。相反的策略可以帮助降低自身免疫和移植过程中致病性T细胞的频率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nevil John Singh其他文献
Nevil John Singh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nevil John Singh', 18)}}的其他基金
Mechanisms coordinating the local and systemic resistance to pathogens
协调局部和全身对病原体的抵抗力的机制
- 批准号:
10587868 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别:
An IL-12 family heterodimer that regulates IL-4 production by T cells
调节 T 细胞产生 IL-4 的 IL-12 家族异二聚体
- 批准号:
10495254 - 财政年份:2021
- 资助金额:
$ 38.37万 - 项目类别:
An IL-12 family heterodimer that regulates IL-4 production by T cells
调节 T 细胞产生 IL-4 的 IL-12 家族异二聚体
- 批准号:
10353589 - 财政年份:2021
- 资助金额:
$ 38.37万 - 项目类别:
Mechanisms maintaining the self-awareness of peripheral T cells
维持外周T细胞自我意识的机制
- 批准号:
9979091 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Mechanisms maintaining the self-awareness of peripheral T cells
维持外周T细胞自我意识的机制
- 批准号:
10242775 - 财政年份:2020
- 资助金额:
$ 38.37万 - 项目类别:
Modifying T Cell Responses by Combinatorial Targeting of Negative regulators
通过负调节剂的组合靶向改变 T 细胞反应
- 批准号:
8874742 - 财政年份:2014
- 资助金额:
$ 38.37万 - 项目类别:
Role of sub-activation-threshold TCR interactions in maintaining T cell memory
亚激活阈值 TCR 相互作用在维持 T 细胞记忆中的作用
- 批准号:
8975607 - 财政年份:2014
- 资助金额:
$ 38.37万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 38.37万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 38.37万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 38.37万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 38.37万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 38.37万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 38.37万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 38.37万 - 项目类别:














{{item.name}}会员




